search
Back to results

Evaluation of Vertebroplasty Associated With Radiotherapy for Spine Metastases (EVAR)

Primary Purpose

Osseous Spine Metastases

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
injection of orthopaedic cement into vertebral bodies
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osseous Spine Metastases focused on measuring Neoplasm Metastasis, Bone Neoplasms, Pain, Radiotherapy, Vertebroplasty, Combined modality therapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Osseous spine metastases from squamous cell carcinoma or adenocarcinoma One to four painful metastases located between the second cervical vertebra and the fifth lumbar vertebra Moderate to severe pain No spinal cord compression Karnofsky performance status > 40 Exclusion Criteria: Previous radiotherapy or surgery Vertebral fracture or any other formal indication of stabilization of the rachis by surgery or vertebroplasty Spinal cord compression Known anomaly of the haemostasis, or needed anticoagulant treatment

Sites / Locations

  • CHU Pitié-Salpétrière

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

1

Arm Description

injection of orthopaedic cement into vertebral bodies

Outcomes

Primary Outcome Measures

Evaluation of pain relief with the Brief Pain Index (BPI), by a blind arm trial algologist, 3 months after radiotherapy.
Response will be scored as complete (no pain), partial (improvement of < 2 points in BPI), stable (+/- 1 point change in BPI) or progressive (> 2 point worsening of BPI).
Complete and partial responses will be considered treatment success, and stable and progressive responses will be considered treatment failures

Secondary Outcome Measures

Evaluation of pain relief one month after radiotherapy
BPI-SF and EORTC QLQ-C30 will be used to assess general cancer quality of life.
The incidence of vertebral pathologic fracture will be registered.

Full Information

First Posted
December 19, 2005
Last Updated
December 1, 2008
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT00267033
Brief Title
Evaluation of Vertebroplasty Associated With Radiotherapy for Spine Metastases (EVAR)
Official Title
Randomized Trial of Vertebroplasty and Radiotherapy Versus Radiotherapy Alone for Osseous Spine Metastases
Study Type
Interventional

2. Study Status

Record Verification Date
March 2007
Overall Recruitment Status
Completed
Study Start Date
November 2005 (undefined)
Primary Completion Date
February 2008 (Actual)
Study Completion Date
August 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
A randomized phase III study of palliative external beam radiotherapy (RTOG 97-14) has shown that 8 Gy in a single fraction is very effective in providing pain relief, with complete or partial improvement in pain seen in 66% of patients with bone metastases. Percutaneous vertebroplasty (PV) is a technique designed to consolidate pathologic vertebral bodies through the injection of orthopaedic cement under fluoroscopic guidance. Consolidation provides rapid pain relief to painful vertebral body lesions secondary to osteoporosis, haemangiomas, myeloma and metastatic diseases, with complete or partial improvement in pain seen in 70-85% of patients. To date, no randomized trial has tested the association of vertebroplasty and radiotherapy to enhance pain relief for patients with painful osseous spine metastases. A randomized trial has been designed to determine whether vertebroplasty and radiotherapy (8 Gy in a single fraction) provide enhancement pain and narcotic relief compared to radiotherapy alone for patients with painful osseous spine metastases
Detailed Description
Patients with 1 to 4 painful osseous spine metastases are randomized to 1 of 2 treatment arms: Arm 1: 8 Gy in a single fraction Arm 2: 8 Gy in a single fraction followed by vertebroplasty of the vertebral bodies, within 14 days after radiotherapy

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osseous Spine Metastases
Keywords
Neoplasm Metastasis, Bone Neoplasms, Pain, Radiotherapy, Vertebroplasty, Combined modality therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
186 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
injection of orthopaedic cement into vertebral bodies
Intervention Type
Procedure
Intervention Name(s)
injection of orthopaedic cement into vertebral bodies
Intervention Description
injection of orthopaedic cement into vertebral bodies
Primary Outcome Measure Information:
Title
Evaluation of pain relief with the Brief Pain Index (BPI), by a blind arm trial algologist, 3 months after radiotherapy.
Time Frame
3 months after radiotherapy
Title
Response will be scored as complete (no pain), partial (improvement of < 2 points in BPI), stable (+/- 1 point change in BPI) or progressive (> 2 point worsening of BPI).
Time Frame
during the study
Title
Complete and partial responses will be considered treatment success, and stable and progressive responses will be considered treatment failures
Time Frame
during the study
Secondary Outcome Measure Information:
Title
Evaluation of pain relief one month after radiotherapy
Time Frame
one month after radiotherapy
Title
BPI-SF and EORTC QLQ-C30 will be used to assess general cancer quality of life.
Time Frame
during the study
Title
The incidence of vertebral pathologic fracture will be registered.
Time Frame
one month after radiotherapy

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Osseous spine metastases from squamous cell carcinoma or adenocarcinoma One to four painful metastases located between the second cervical vertebra and the fifth lumbar vertebra Moderate to severe pain No spinal cord compression Karnofsky performance status > 40 Exclusion Criteria: Previous radiotherapy or surgery Vertebral fracture or any other formal indication of stabilization of the rachis by surgery or vertebroplasty Spinal cord compression Known anomaly of the haemostasis, or needed anticoagulant treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
jean-Marc SIMON, MD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Pitié-Salpétrière
City
Paris
ZIP/Postal Code
75013
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
15928300
Citation
Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005 Jun 1;97(11):798-804. doi: 10.1093/jnci/dji139.
Results Reference
background
PubMed Identifier
8633152
Citation
Weill A, Chiras J, Simon JM, Rose M, Sola-Martinez T, Enkaoua E. Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology. 1996 Apr;199(1):241-7. doi: 10.1148/radiology.199.1.8633152.
Results Reference
background

Learn more about this trial

Evaluation of Vertebroplasty Associated With Radiotherapy for Spine Metastases (EVAR)

We'll reach out to this number within 24 hrs